Silvana Gaudieri - Infectious Diseases

Author Information

Silvana Gaudieri is a prominent researcher affiliated with the School of Human Sciences at the University of Western Australia and the Institute for Immunology and Infectious Diseases at Murdoch University, both located in Western Australia. Additionally, she is associated with the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center in Tennessee, USA. Her diverse affiliations highlight her active involvement in both national and international research communities, particularly in the fields of human sciences and infectious diseases.

Research Contributions

Silvana Gaudieri has made significant contributions to a variety of research areas including immunology, infectious diseases, and genomics. Her work encompasses studying viral genetics and host immune responses, such as her research on the UL111a gene in HCMV and SARS-CoV-2 sub-genomic RNA expression. Her studies have also explored innovative approaches in genetic and epigenetic editing using CRISPR technology, particularly in the context of tumor immunity and the NKG2D receptor-ligand axis. This broad spectrum of research underscores her role in advancing scientific understanding of disease mechanisms and potential therapeutic interventions.

Aliases

Silvana Gaudieri is also known in academic circles by variations of her name, including S Gaudieri and S. Gaudieri. These aliases are used interchangeably in her publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	6203
h-index	40
Total Paper Count	250

Publications:

Sequencing of the Viral UL111a Gene Directly from Clinical Specimens Reveals Variants of HCMV-Encoded IL-10 That Are Associated with Altered Immune Responses to HCMV

DOI: 10.3390/ijms23094644

Year: 2022

Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress

DOI: 10.7717/peerj.10776

Year: 2021

Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing

DOI: 10.1016/j.omtm.2021.04.009

Year: 2021

Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity

DOI: 10.3389/fimmu.2021.712722

Year: 2021

Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections

DOI: 10.1101/2021.03.02.433156

Year: 2021

Dynamic changes to tissue-resident immunity after MHC-matched and MHC-mismatched solid organ transplantation.

DOI: 10.1016/j.celrep.2021.109141

Year: 2021

Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data

DOI: 10.1101/gr.268110.120

Year: 2021

Single cell multi-omics reveals early elevated function and multiple fates within human progenitor exhausted CD8+ T cells

DOI: 10.1101/2021.09.09.459584

Year: 2021

The adjacent amino acid polymorphisms in the nucleocapsid (R203K/G204R) of SARS-

DOI:

Year: 2021

Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level

DOI: 10.20411/pai.v6i2.460

Year: 2021

How do Bacteria Cause Diseases?

What Are the Common Symptoms of Immunodeficiency Disorders?

How does Dengvaxia work?

How Can Dengue Hemorrhagic Fever be Prevented?

How Can Individuals Support CDC's Efforts?

How Are Epidemiological Studies Conducted?

How to Combat Antimicrobial Resistance?

What role does global travel play in the spread of infectious diseases?

What is AIDS?

How Do Viruses Spread?

Partnered Content Networks

Relevant Topics